Mercy Medical Center Nurses Represented by the Massachusetts Nurses Association and Supporters to Picket Outside Springfield Hospital August 24

To Fight Back Against Owner Trinity Health's Refusal to Bargain in Good Faith and Protect and Support Nurses

Registered nurses at Mercy Medical Center represented by the Massachusetts Nurses Association will join supporters for an informational picket on August 24 to bring attention to hospital owner Trinity Health’s failure to respect the rights of nurses, listen to their concerns and support and protect them during the ongoing COVID-19 pandemic.

Informational Picket Info
When: Monday, Aug. 24 from 4 to 5 p.m.
Where: On the sidewalk outside Mercy on Carew Street in Springfield
How: Nurses, healthcare workers and community supporters will don masks and maintain responsible social distances as they picket. Media are welcome to attend and follow similar social distancing guidelines.

“Trinity Health barrels ahead with changes that negatively impact nurses and our working conditions while publicly praising its frontline workers,” said Jaime Dorunda, RN and Co-Chair of the MNA Bargaining Committee at Mercy Medical Center. “Trinity has changed our schedules and hours and refuses to implement recommendations we make to protect staff and patients.”

“Trinity’s behavior is demoralizing after nurses and our frontline colleagues have worked hard to safely care for patients under extremely challenging conditions for months.” said Alex Wright, RN and Co-Chair of the MNA Bargaining Committee at Mercy Medical Center. “They are not listening to nurses and healthcare workers on the front lines and are ignoring our concerns.”

  • Mercy Medical Center management and corporate owner Trinity Health are not respecting nurses by refusing to bargain in good faith and are making unilateral changes to RN schedules, hours and working conditions
  • Trinity is targeting poor/unfair treatment toward more experiencing nurses and does not care about retaining them
  • Trinity has ignored RN recommendations on protective equipment, staffing, and other safety measures during COVID-19
  • Despite its enormous resources – Trinity earns $19 billion a year nationally and has received at least $600 million in COVID-19 relief money – Trinity cuts corners and refuses to support frontline staff, creating unsafe and unfair working conditions

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”